<DOC>
	<DOCNO>NCT00846781</DOCNO>
	<brief_summary>The purpose study obtain data potential long-term treatment denufosol improve clinical course CF lung disease patient mildly impaired lung function provide CF patient complete study 08-110 continued access denufosol .</brief_summary>
	<brief_title>Study 08-114 Open-label Extension Study 08-110 - A Multi-Center Study Denufosol Tetrasodium Inhalation Solution Patients With Cystic Fibrosis Lung Disease ( P08642 )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Completed Study 08110 A female patient eligible study childbearing potential pregnant , lactating , and/or practice acceptable method birth control ( e.g. , abstinence , hormonal barrier method , partner sterilization , intrauterine device ) . Have condition might affect compliance study procedure</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>